CTRI/2019/04/018773尚未招募3 期
Effectiveness and Safety of 6 months versus standard 2 months intramuscular adrenocorticotropic hormone/oral steroids therapy in infants with West Syndrome: A Randomized Controlled Trial - EAST Trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •(1)Infants 2 to 24 months of age; (2) the diagnosis of West Syndrome confirmed by clinical assessment and EEG; and (3) Initiated on ACTH/steroids therapy and cessation of spasms at 6 weeks of therapy (4) Written informed consent from a parent
排除标准
- •(1) Declined to provide written informed consent by parents, (2) Suspected or proven cases of tuberous sclerosis, (3) Suspected or proven neurometabolic disease, degenerative brain disease and any progressive neurologic disease other than West syndrome, and (4) Inability by parents to come for follow-up
研究者
相似试验
招募中
3 期
A study to compare effectiveness for preventing disease recurrence and safety regarding drug related side effects between one month vs. two month of alternate day oral steroid in children with nephrotic syndrome, a chronic protein losing kidney disease.CTRI/2015/01/005363RS Medical College and Hospital120
进行中（未招募）
不适用
Comparison of treatment of blood clots in the veins of the leg / pelvis as well as of blood clots in the lung of patients with active cancer. The treatments compared are Innohep® Treatment Versus Warfarin , an oral Vitamin K antagonist.EUCTR2009-018141-20-LVEO Pharma A/S900
进行中（未招募）
不适用
Comparison of treatment of blood clots in the veins of the leg / pelvis as well as of blood clots in the lung of patients with active cancer. The treatments compared are Innohep® Treatment Versus Warfarin , an oral Vit. K antagonist.EUCTR2009-018141-20-PTEO Pharma A/S900
进行中（未招募）
不适用
Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation with a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients / IN 0901 INT - CATCHThromboembolism (VTE) in patients with active cancerMedDRA version: 12.1Level: LLTClassification code 10066899Term: Venous thromboembolismEUCTR2009-018141-20-GREO Pharma A/S900
进行中（未招募）
3 期
Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation with a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients / IN 0901 INTCTRI/2010/091/000598EO Pharma AS1,000